[1st report on programmed chemotherapy of ovarian carcinoma]

Frank S, S Frank, Richter K, K RICHTER, H Ehrhart, Ehrhart H, W Penning, Penning W, Meister P, P Meister, Schmidt D, D. Schmidt, A Götz, Götz A
Fortschritte der Medizin · 1975 · vol. 93(28) , pp. 1309–12 · PMID:1228086
Non-randomised trial public-domain-us
View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

This report details the team-based, synchronized cytostatic drug combination treatment of advanced ovarian carcinoma based on experiences with 41 patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A prospective study with regard to a cytostatic drugs combination treatment, partly synchronized and carried out in team work, of advanced ovarian carcinoma is being accomplished at the II. Women's Clinic of the University of Munich. The team consists of one oncologically orientated internal specialist, one radiotherapist, and one surgeon. The therapeutic procedure should be discussed; a report is given about the experiences gained so far in 41 patients, i.e. until May 1st, 1975.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Antineoplastic Agents Antineoplastic Agents Cyclophosphamide Cyclophosphamide Cyclophosphamide Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Cystadenoma Cystadenoma Cystadenoma Drug Therapy, Combination Drug Therapy, Combination Endometriosis Endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:00:38.508852+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine